Regulatory News
Wednesday, June 29, 2016
UPDATE 1-Shire says ADHD drug meets main goal of study
June 29 (Reuters) - Irish drugmaker Shire Plc said a
study testing an experimental drug to treat attention-deficit
disorder met the main goal, bringing the drug one step closer to
approval in the...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment